Torrey Growth & Income Advisors
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2087822
DEL MAR, CA
Position in VRTX
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$2,103,203
-$36,202 QoQ
Shares Held
4,710
-0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Torrey Growth & Income Advisors holds $5,840,491 across 8 Biotechnology names. VRTX ranks #1 (36.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
4,710 | $2,103,203 | |
| 2 | VCEL |
Vericel Corp
|
44,683 | $1,437,452 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
70,547 | $904,412 | |
| 4 | MRNA |
Moderna, Inc.
|
9,350 | $474,980 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
55,450 | $425,301 | |
| 6 | CADL |
Candel Therapeutics, Inc.
|
67,148 | $329,025 | |
| 7 | BCAB |
BioAtla, Inc.
|
15,687 | $126,280 | |
| 8 | SPRO |
Spero Therapeutics, Inc.
|
17,025 | $39,838 |
All Filings in VRTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,103,203 | 4,710 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,139,405 | 4,719 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,114,856 | 5,400 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||